Mitochondria: The Common Upstream Driver of Amyloid-β and Tau Pathology in Alzheimers Disease

Author(s): D. F.F. Silva, A. R. Esteves, C. R. Oliveira, S. M. Cardoso.

Journal Name: Current Alzheimer Research

Volume 8 , Issue 5 , 2011

Become EABM
Become Reviewer

Abstract:

Mitochondrial dysfunction has been widely implicated in the etiology of Alzheimers disease (AD). Evidence shows a mitochondrial-mediated impairment of autophagy that potentiates amyloid-β (Aβ) deposition. Accordingly, recent data obtained from AD models, in which mitochondrial alterations are a prominent feature, demonstrated abnormalities in microtubule network, involving tubulin and tau post-translational modifications. In this review we will discuss mitochondrial- regulated processes where mitochondrial malfunction is likely to start a sequence of events leading to sirtuin- 2 activation, microtubule network breakdown, and impairment of the autophagic pathway. Because sirtuin-2 activity depends on cellular NAD+ availability, mitochondrial regulation of NAD+ levels may contribute to an increase in sirtuinmediated tubulin deacetylation. A vicious cycle become installed which potentiates tau hyperphosphorylation, together with Aβ overproduction and deposition. Overall, targeting microtubule network constitutes a promising strategy for pharmacological therapy in AD.

Keywords: Alzheimer's disease, amyloid-β, autophagy, microtubule network, mitochondria, tau, calcium homeostasis, oxidative phosphorylation, AD development, oxidative stress markers, neurodegeneration, mitochondrial integrity, resonance spectroscopy

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 5
Year: 2011
Page: [563 - 572]
Pages: 10
DOI: 10.2174/156720511796391872
Price: $58

Article Metrics

PDF: 21